RAD54L Gene Mutation
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer (NCT03377556) | SWOG Cancer Research Network | 2017-03-03 |
Track RAD54L Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.